Bright! FRONTEO Official Blog

Bright! FRONTEO Official Blog

[3/14 FRONTEO Life Science AI Business Academy] Promotion of DX in drug discovery research undertaken by Daiichi Sankyo

Daiichi Sankyo Medicinal Chemistry Research Laboratories started promoting data-driven drug discovery (D4: Data-Driven Drug Discovery) in 2019 to realize DX in medicinal chemistry research. By promoting D4, we aim to accelerate and improve the efficiency of the process up to the creation of development candidates, and to foster a culture that enables highly accurate decisions based on data.
As these measures, we have transformed the entire research process based on three main points: human resource development, data maintenance, and compound management.Specifically, in terms of human resource development, an AI drug discovery specialist group was newly established within the research institute, and a system for cyclically developing hybrid human resources of medicinal chemists and data scientists was constructed.Regarding data maintenance, we are expanding the data utilization infrastructure, such as introducing visualization tools for data analysis and building prediction methods and structure generation methods using AI.In terms of compound management, we are improving compound logistics through a sample management system and operating the HTS library from a long-term perspective.

 

Click here for registration and seminar details:https://lifescience.fronteo.com/webinar20230314


【Webinar Summary】

◆ Theme: Promotion of DX in drug discovery research undertaken by Daiichi Sankyo
 
Date: 3/14 (Tue) 18:00-19:00
 
◆ Format: Free web seminar (only PC environment that can connect to the Internet is required)
 
◆ Participation conditions:
We kindly ask that you refrain from applying if you are using a free address, if you are in the same industry as our company, or if you do not know your affiliation.When accessing ZOOM on the day, please enter the name and email address you entered at the time of application in the ZOOM participation entry field.
 

 
◆Speakers

Daiichi Sankyo Co., Ltd.
Director, Medicinal Chemistry Research Laboratories, Research Division, Research and Development Division
Mr. Kazuma Aoki
 
Born in Tokyo in 1966.He graduated from the Faculty of Pharmaceutical Sciences, University of Tokyo.He completed the doctoral course at the Graduate School of Pharmaceutical Sciences.He joined Sankyo Co., Ltd. in 1998 after working as a research fellow of the Japan Society for the Promotion of Science, a postdoctoral researcher at the Massachusetts Institute of Technology, and an assistant at the Faculty of Pharmaceutical Sciences at the University of Tokyo. Incumbent since April 2019.He is engaged in small and middle molecule drug discovery research.He is a director of the Pharmaceutical Society of Japan, a vice-chairman of the Pharmaceutical Chemistry Subcommittee of the Pharmaceutical Society of Japan, and a director of the Synthetic Organic Chemistry Society of Japan.
Share this article